CXCL10

There are 84 papers on CXCL10 in aging research: 1 trial and 27 observational studies in people, 43 in animals, 8 in cells, 4 reviews. The newest story, Oct 4, 2026: “Plasma CXCL10 links to higher stroke risk in older adults”.

Gene

84 papers study it4 findings

HGNCNCBI GeneTaxon

4 new papers in 30 daysSee all 84 papers on CXCL10

At a glance

The findings reach people, from one lab or study. 3 independent labs in 2 countries.

“The Logistic regression analysis revealed that the positive group had lower levels of CXCL10 (OR = 0.951; CI: 0.907 − 0.997; P < 0.05) after correcting for covariate weakening.”
Immune Response to COVID-19 Vaccination in Frail PatientsResearch Square2024doi:10.21203/rs.3.rs-3896432/v1

None of its findings points the other way.

Mice and humans: a single group. Cells and worms or flies: nothing yet.
  • 3 independent labs in 2 countries
  • Funders: Bundesministerium für Bildung und Forschung and others
  • Human trial1
  • Humans27
  • Animals43
  • Cells8
  • In silico1

Effects

1

CD8+ T cell recruitment

mediatesin mice1

1 study
  1. CXCL10 mediates CD8+ T cell recruitment in mice.

    Animalswhite matter

Associations

3

Telomere length

mixedin silico1

1 study
  1. CXCL10 is associated with telomere length in silico.

    In silico

More on Telomere length

ALM

upin humans1OR 1.01

1 study
  1. CXCL10 is associated with ALM in humans (OR: 1.010, 95% CI: 1.000-1.019, p = 0.042).

    Humans

More on ALM

COVID-19 vaccine

downin humans1OR 0.951

1 study
  1. COVID-19 vaccine is associated with CXCL10 in humans after correcting for covariate weakening (OR = 0.951; CI: 0.907 − 0.997; P < 0.05).

    Humansafter correcting for covariate weakening

More on COVID-19 vaccine

Latest

Dec 2025: 3Jan 2026: 2Feb 2026: 3Mar 2026: 3Apr 2026: 2May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 2Sep 2026: 0Oct 2026: 2Nov 2026: 321 papers in 12 months
The Journal of Bone and Joint Surgery American Volume

Compound improved rotator cuff healing in aged rats

In an experiment involving 48 rats, a drug-loaded gel improved tissue organization and tendon-to-bone strength after shoulder tendon repair in aged animals compared with…In an experiment involving 48 rats, a drug-loaded gel improved tissue organization and tendon-to-bone strength after shoulder tendon repair in aged animals compared with gel alone.

Rat study · 48 ratsInterventions
ESC Congress 2026 Abstract

Thymus suppression protects hearts from a cancer drug in mice

In 12-week-old and 16-month-old mice given cancer immunotherapy, heart pumping decline occurred in young animals but was absent in aged mice and prevented by thymus…In 12-week-old and 16-month-old mice given cancer immunotherapy, heart pumping decline occurred in young animals but was absent in aged mice and prevented by thymus suppression.

Translational Stroke Research

Plasma CXCL10 links to higher stroke risk in older adults

Each 1-standard deviation higher CXCL10 was linked to 20% greater stroke risk over a median follow-up of 14 years.Each 1-standard deviation higher CXCL10 was linked to 20% greater stroke risk over a median follow-up of 14 years.

Cohort study of 1,175 peopleCXCL10
Geromedicine

Protein variant lowered inflammation-linked gene activity in mice

Experiments in mice with premature aging and naturally aged mice found lower activity of a gene for an inflammatory signal, with four or five animals per group.Experiments in mice with premature aging and naturally aged mice found lower activity of a gene for an inflammatory signal, with four or five animals per group.

Mouse studyInterventions

See all 84 papers on CXCL10